Physician profile
Elson Haas
NPI 1740318112
$1,509.79
in general payments reported to CMS, 2019-2025
17 companies · $29.07 in 2025
The $29.07 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $321 · 2021: $311 · 2022: $203 · 2023: $57.03 · 2024: $194 · 2025: $29.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $275.91 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $235.53 | 2019-2021 | |
| Lilly USA, LLC | $176.59 | 2019-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $166.53 | 2024 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135.36 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $119.72 | 2020-2021 | |
| Ibsa Pharma INC. | $115.49 | 2019-2021 | |
| Bausch Health US, LLC | $48.40 | 2020-2021 | |
| Ascend Therapeutics US, LLC | $45.11 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $43.56 | 2022 | |
| Alk-Abello, INC | $27.24 | 2019 | |
| Exact Sciences Corporation | $27.14 | 2024 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $23.44 | 2020 | |
| Allergan, INC. | $20.83 | 2020 | |
| Therapeuticsmd, INC. | $16.77 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $16.67 | 2022 | |
| Phadia US INC. | $15.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elson Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.